Insider Transactions in Q3 2021 at Medtronic PLC (MDT)
Insider Transaction List (Q3 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 30
2021
|
Bradley E Lerman SVP General Counsel & Corp Sec |
SELL
Open market or private sale
|
Direct |
49,147
-50.2%
|
$6,192,522
$126.58 P/Share
|
Sep 30
2021
|
Bradley E Lerman SVP General Counsel & Corp Sec |
BUY
Exercise of conversion of derivative security
|
Direct |
49,147
+33.42%
|
$3,833,466
$78.0 P/Share
|
Aug 31
2021
|
Bradley E Lerman SVP General Counsel & Corp Sec |
SELL
Open market or private sale
|
Direct |
50,775
-51.01%
|
$6,803,850
$134.17 P/Share
|
Aug 31
2021
|
Bradley E Lerman SVP General Counsel & Corp Sec |
BUY
Exercise of conversion of derivative security
|
Direct |
50,775
+33.78%
|
$3,757,350
$74.84 P/Share
|
Aug 25
2021
|
Geoffrey Martha Chairman and CEO |
SELL
Open market or private sale
|
Direct |
11,581
-5.53%
|
$1,528,692
$132.67 P/Share
|
Aug 25
2021
|
Geoffrey Martha Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,581
+5.1%
|
$683,279
$59.04 P/Share
|
Aug 25
2021
|
Sean Salmon EVP & President Cardiovascular |
SELL
Open market or private sale
|
Direct |
28,419
-28.37%
|
$3,808,146
$134.08 P/Share
|
Aug 25
2021
|
Sean Salmon EVP & President Cardiovascular |
BUY
Exercise of conversion of derivative security
|
Direct |
28,419
+15.02%
|
$1,079,922
$38.61 P/Share
|
Aug 02
2021
|
Jennifer M Kirk Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,143
+11.99%
|
-
|
Aug 02
2021
|
Richard Kuntz SVP & Chief Medical & Science |
BUY
Grant, award, or other acquisition
|
Direct |
5,029
+6.29%
|
-
|
Aug 02
2021
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Payment of exercise price or tax liability
|
Direct |
4,905
-6.56%
|
$642,555
$131.31 P/Share
|
Aug 02
2021
|
Bradley E Lerman SVP General Counsel & Corp Sec |
BUY
Grant, award, or other acquisition
|
Direct |
6,019
+10.99%
|
-
|
Aug 02
2021
|
Bradley E Lerman SVP General Counsel & Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
5,450
-11.31%
|
$713,950
$131.31 P/Share
|
Aug 02
2021
|
Bradley E Lerman SVP General Counsel & Corp Sec |
SELL
Open market or private sale
|
Direct |
4,000
-7.66%
|
$524,000
$131.52 P/Share
|
Aug 02
2021
|
John R Liddicoat EVP & President of Americas |
BUY
Grant, award, or other acquisition
|
Direct |
3,353
+7.26%
|
-
|
Aug 02
2021
|
John R Liddicoat EVP & President of Americas |
SELL
Payment of exercise price or tax liability
|
Direct |
3,258
-7.62%
|
$426,798
$131.31 P/Share
|
Aug 02
2021
|
Geoffrey Martha Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
19,047
+16.58%
|
-
|
Aug 02
2021
|
Geoffrey Martha Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,450
-6.63%
|
$713,950
$131.31 P/Share
|
Aug 02
2021
|
Karen L Parkhill EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,162
+7.7%
|
-
|
Aug 02
2021
|
Karen L Parkhill EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,839
-8.0%
|
$895,909
$131.31 P/Share
|
Aug 02
2021
|
Sean Salmon EVP & President Cardiovascular |
BUY
Grant, award, or other acquisition
|
Direct |
5,486
+14.13%
|
-
|
Aug 02
2021
|
Sean Salmon EVP & President Cardiovascular |
SELL
Payment of exercise price or tax liability
|
Direct |
2,272
-7.54%
|
$297,632
$131.31 P/Share
|
Aug 02
2021
|
Carol A Surface EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,657
+9.63%
|
-
|
Aug 02
2021
|
Carol A Surface EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,997
-11.53%
|
$523,607
$131.31 P/Share
|
Aug 02
2021
|
Hoedt Rob Ten EVP and Pres. Global Regions |
BUY
Grant, award, or other acquisition
|
Direct |
4,419
+9.04%
|
-
|
Aug 02
2021
|
Hoedt Rob Ten EVP and Pres. Global Regions |
SELL
Payment of exercise price or tax liability
|
Direct |
3,908
-8.89%
|
$511,948
$131.31 P/Share
|
Aug 02
2021
|
Brett A. Wall EVP & Pres Neuroscience |
BUY
Grant, award, or other acquisition
|
Direct |
5,333
+17.36%
|
-
|
Aug 02
2021
|
Brett A. Wall EVP & Pres Neuroscience |
SELL
Payment of exercise price or tax liability
|
Direct |
1,482
-6.88%
|
$194,142
$131.31 P/Share
|
Aug 02
2021
|
Robert John White EVP & Pres. Medical Surgical |
BUY
Grant, award, or other acquisition
|
Direct |
6,095
+11.53%
|
-
|
Aug 02
2021
|
Robert John White EVP & Pres. Medical Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
4,897
-10.75%
|
$641,507
$131.31 P/Share
|